Drug Database · Clinicians

Betamethasone diproprionate + Clotrimazole + Gentamicin

Brands (2) Clobgen, Healthcare TridermShow all

Antifungal (imidazole and triazole derivative) + antibacterial (aminoglycoside) + corticosteroid; Topical anti-infective PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • betamethasone diproprionate no separate page
  • Use: INDICATIONS AND USAGE Clotrimazole cream USP is indicated for the topical treatment of candidiasis due to Candida albicans and tinea versicolor due to Malassezia furfur. US FDA label

  • Use: INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Sulfate in 0.9% Sodium Chloride Injection and other antibacterial drugs, Gentamicin Sulfate in 0.9%… US FDA label

    Kidney dosing: Gentamicin (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Normal kidney function: 3 mg/kg/day in 3 doses every 8 hours; up to 5 mg/kg/day for life-threatening infection, reduced as soon as possible. Obese patients: dose by lean body mass. Measure peaks (4 to 6 mcg/mL) and troughs (label). Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels.
    CrCl 30–59 mL/min
    After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4 examples: CrCl about 40–45 (SCr 2–2.2): 50%; 30–35 (SCr 2.6–3): 35% of the usual dose every 8 hours. Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
    CrCl 15–29 mL/min
    After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4 example: CrCl about 20–25: 25%; 15–20: 20% of the usual dose every 8 hours. Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
    CrCl <15 mL/min (not on dialysis)
    After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4: CrCl about 10–15: 15%; under 10: 10% of the usual dose every 8 hours. Specialist input. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
    Hemodialysis (intermittent)
    1 to 1.7 mg/kg at the end of each dialysis, depending on severity of infection; an 8-hour hemodialysis lowers levels by about 50% (label). Check levels.
    Peritoneal dialysis
    No PD dose in label; removal by peritoneal dialysis is much slower than by hemodialysis. For PD-associated peritonitis (ISPD 2022): 0.6 mg/kg intraperitoneally once daily, intermittent (in one exchange daily with a dwell of at least 6 hours); continuous dosing is not advised. Check levels; specialist input.
    CRRT
    No data in label, and gentamicin is not in the Li 2020 CRRT table. Level-guided dosing with specialist input.
    • Dialyzable? Yes by hemodialysis (about 50% over 8 hours; label); much less by peritoneal dialysis. Protein binding 0% to 30%.
    • Monitoring Peak and trough levels; serum creatinine before and during therapy; urinalysis; hearing and vestibular function; magnesium, calcium and potassium (wasting, Fanconi-like syndrome reported). Avoid other nephrotoxic drugs and potent diuretics.

    From the Gentamicin monograph (renalcarematters.com, reviewed).

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per gram cream: 500 mcg/10 mg/1 mg
  • Per gram topical cream: 500 mcg/10 mg/1 mg

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Betamethasone diproprionate + Clotrimazole + Gentamicin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Betamethasone diproprionate + Clotrimazole + Gentamicin
Package insert
ClobgenBetamethasone Diproprionate + Clotrimazole + Gentamicin Sulfate
500 mcg/10 mg/1 mg per gram (0.05%/1%/0.1% w/w) Topical CreamCollapsible aluminium tubes x 10 g and 20 g
Rx
Front Pharmaceutical PLCChina
AMB HK Enterprises, Inc.
DRP-18997
Oct 15, 2031
Healthcare TridermBetamethasone Diproprionate + Clotrimazole + Gentamicin Sulfate
500 mcg/10 mg/1 mg per gram (0.05% / 1% / 0.1% w/w) CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
—
DR-XY39473 (FOR EXPORT ONLY)
May 18, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .